We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Vienna, Austria

ESTRO 2023

Session

Saturday
May 13
16:45 - 17:45
Hall A
Lower GI
Fatjona Kraja, Albania;
Karen-Lise Spindler, Denmark
Proffered Papers are presented in one of the sessions scheduled in the main session halls. Each author will present orally for 7 minutes, followed by 3 minutes for discussion. Sessions will be recorded and available on-demand.
1510
Proffered Papers
Clinical
16:45 - 16:55
Organ preservation in rectal cancer: the randomised STAR-TREC phase II trial
Corrie Marijnen, The Netherlands
OC-0272
16:55 - 17:05
Quality of life following TNT of rectal cancer in the CAO/ARO/AIO-12 phase 2 trial
Rebekka Kosmala, Germany
OC-0273
17:05 - 17:15
Trend in overall survival after treatment failure in patients with locally advanced rectal cancer
Markus Diefenhardt, Germany
OC-0274
17:15 - 17:25
Timing of surgery after short course radiotherapy for rectal cancer: real-world evidence
Martijn Intven, The Netherlands
OC-0275
17:25 - 17:35
Relationships between microbiome and response to neoadjuvant chemoradiotherapy in rectal cancer
Hye In Lee, Korea Republic of
OC-0276
17:35 - 17:45
Capecitabine or 5-fluorouracil infusion with radiotherapy of anal cancers in the FFCD-Anabase cohort
Anne-Charlotte Delhiat, France
OC-0277